Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Aileron Therapeutics
company
About
Aileron Therapeutics is a biopharmaceutical company that develops a class of drugs called Stapled Peptides.
- 1 - 10
Details
- Last Funding Type
- Post-IPO Secondary
- Last Funding Money Raised
- $35.90M
- Industries
- Biopharma,Biotechnology,Therapeutics
- Founded date
- Jan 1, 2005
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Aileron Therapeutics is a biopharmaceutical company that develops a class of drugs called Stapled Peptides. Stapled Peptides represent the first general solution for modulating intracellular protein-protein interactions that are critical control points to nearly all functions of a cell.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$35.90M
Aileron Therapeutics has raised a total of
$35.90M
in funding over 2 rounds. Their latest funding was raised on
Jan 6, 2021 from a Post-IPO Secondary round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 6, 2021 | Post-IPO Secondary | $35.90M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Aileron Therapeutics is funded by 1 investors.
Maven Investment Partners US
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Post-IPO Secondary |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
